To the best of our knowledge, our study is the first to explore the relationship between the genetic polymorphisms in the NRF2 gene, a vital antioxidant gene, and the risk of CHB, HBV-associated LC and HCC. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.